The mystery of how humans and other animals produce plasmalogens—specialized membrane fats crucial for brain function and cellular protection—has been solved through evolutionary detective work. These lipids, found abundantly in heart muscle and neural tissue, perform vital roles in membrane stability and signaling, yet their sporadic presence across different life forms has puzzled scientists for decades. The discovery reveals that eukaryotic cells acquired the complete genetic toolkit for plasmalogen synthesis through horizontal gene transfer from myxobacteria, a group of soil-dwelling microorganisms known for their complex social behaviors and predatory lifestyle. This transfer event occurred deep in evolutionary history, providing animal lineages with the molecular machinery to manufacture these protective lipids. The research identifies the specific gene cluster responsible for aerobic plasmalogen biosynthesis, explaining why these compounds are particularly enriched in oxygen-demanding tissues like the brain and heart. This finding represents a significant advance in understanding membrane biochemistry evolution, as plasmalogens constitute up to 20% of total phospholipids in human tissues and their deficiency is linked to neurological disorders and aging. The horizontal transfer mechanism also explains the patchy distribution of plasmalogen-producing capabilities across the eukaryotic tree of life. From a longevity perspective, this research illuminates why plasmalogen levels decline with age and why maintaining adequate levels may be crucial for healthy brain aging. The bacterial origin of this pathway suggests potential therapeutic targets for age-related plasmalogen deficiency, possibly through microbiome modulation or targeted supplementation strategies.